At a glance
Selected kisspeptin-54 studies include acute crossover sexual-response experiments and an IVF feasibility study. Fragment, setting and endpoint remain central to interpretation.
Identity & scope
Kisspeptin describes related peptide forms. Both selected trials used kisspeptin-54; the catalogue label does not specify which fragment is supplied.
What the research shows
- Brain-response changes can support a mechanistic hypothesis while leaving long-term patient benefit unresolved.
- Evidence for kisspeptin-54 is not evidence for every peptide fragment carrying the kisspeptin name.
Critical interpretation
Acute arousal experiments need an acute interpretation
The crossover design compares each participant with themselves, reducing confounding from stable differences between people. The male study also standardised stimuli and timing, and excluded several potentially confounding conditions. That improves interpretation of the immediate laboratory response. It does not establish a sustained change in day-to-day desire, relationship outcomes or effectiveness across sexual orientations and clinical groups. Imaging, tumescence and reported experience remain related but distinct measures. [1] [2]
The fertility literature studies another question and a defined fragment
The IVF feasibility study followed oocyte maturation and subsequent pregnancies and births after kisspeptin-54 within a controlled fertility-treatment protocol. These are more direct reproductive outcomes than a hormone response alone. However, the study lacked a randomised standard-trigger comparison and included other essential IVF interventions. It therefore cannot establish superiority to standard triggers or a general fertility effect. All three selected human papers concern kisspeptin-54, leaving the catalogue’s unspecified fragment unresolved. [3]
Limitations & uncertainties
- Small, selected populations and acute study visits limit generalisation.
- The supplied fragment, formulation, exposure and route are not established by these studies.
Open research questions
- Which kisspeptin fragment and molecular form does the material contain?
- Would a longer trial show a meaningful, sustained outcome beyond the immediate laboratory response?
Selected papers & source records
Download bibliography1. Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial (opens in a new tab)
Thurston L, Hunjan T, Ertl N, et al. (2022). JAMA Network Open. DOI: 10.1001/jamanetworkopen.2022.36131 (opens in a new tab) · PMID 36287566
- Design & population
- Double-masked placebo-controlled crossover trial of intravenous kisspeptin-54 in premenopausal women with hypoactive sexual desire disorder;32 completed both visits.
- What the study found
- Kisspeptin-54 altered brain responses to sexual and facial-attraction stimuli. Some imaging changes correlated with baseline distress or sexual aversion.
- Limits on interpretation
- Small acute mechanistic study, primarily using imaging endpoints. It does not establish durable clinical improvement or effects of unspecified kisspeptin fragments.
Original source (opens in a new tab) · Full text at publisher / archive (opens in a new tab)
2. Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial (opens in a new tab)
Mills EG, Ertl N, Wall MB, et al. (2023). JAMA Network Open. DOI: 10.1001/jamanetworkopen.2022.54313 (opens in a new tab) · PMID 36735255
- Design & population
- Double-blind placebo-controlled crossover trial of intravenous kisspeptin-54;32 men with hypoactive sexual desire disorder completed both study visits.
- What the study found
- Brain responses to sexual stimuli changed; secondary analyses found increased penile tumescence and some self-reported arousal measures.
- Limits on interpretation
- Acute laboratory endpoints in 32 right-handed heterosexual men. Full-text methods and limitations were consulted. Generalisation to other groups or sustained real-world sexual outcomes remains unresolved.
Original source (opens in a new tab) · Full text at publisher / archive (opens in a new tab)
3. Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization (opens in a new tab)
Jayasena CN, Abbara A, Comninos AN, et al. (2014). Journal of Clinical Investigation. DOI: 10.1172/JCI75730 (opens in a new tab) · PMID 25036713
- Design & population
- Dose-finding feasibility study in 53 women undergoing a controlled IVF protocol. Oocyte maturation was the primary endpoint; pregnancies and births were followed.
- What the study found
- Egg maturation and subsequent pregnancies and live births were observed after kisspeptin-54 within the IVF protocol.
- Limits on interpretation
- No randomized standard-trigger comparison. Concomitant fertility treatment and the selected setting prevent assigning a general fertility benefit to an unspecified kisspeptin fragment.
Original source (opens in a new tab) · Full text at publisher / archive (opens in a new tab)
Search & review scope
Targeted web searches of PubMed-indexed primary research and original journal records. Selected abstracts and citation metadata were checked; full-text sections were consulted for the records explicitly labelled full-text. Retrieved records and targeted notice searches were also checked for visible corrections or retractions.. Checked 9 November 2026.
Selected primary research relevant to the named compound, its molecular specification and the endpoints described below.
Narrative selection, not a systematic review, comprehensive safety assessment or complete retraction audit. PubMed/PMC full-text access was intermittent. An abstract or selected-section review cannot replace appraisal of the complete methods, supplements and underlying data. Absence from this selection does not establish absence of research.
Recorded search terms
- 36287566 kisspeptin
- "Effects of Kisspeptin Administration in Women" "Abstract"
- site.pubmed.ncbi.nlm.nih.gov kisspeptin 54 oocyte maturation IVF live birth 2014
- site.pmc.ncbi.nlm.nih.gov/articles/PMC9898824 "Limitations"
Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.
Cite this review
HeartPep. Kisspeptin: literature review. HeartPep literature library. Reviewed 9 November 2026. https://heartpep.com/uk/research/library/kisspeptin.
HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.
Buy from HeartPep.com
Laboratory research only. Not for human or veterinary use.